Exact Sciences Corp, Ironwood deal

The companies will co-promote Exact’s colorectal cancer test Cologuard in the U.S. under a one-year, non-exclusive deal, which can be extended. Cologuard is a non-invasive stool DNA test that utilizes a multiplexed quantitative Invader assay for the simultaneous detection of methylated and unmethylated sequences in the promoter region of the vimentin (VIM) gene. ...